IQVIA Holdings Inc. (NYSE:IQV) Shares Bought by MML Investors Services LLC

MML Investors Services LLC boosted its position in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 6.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 134,396 shares of the medical research company's stock after purchasing an additional 7,980 shares during the period. MML Investors Services LLC owned approximately 0.07% of IQVIA worth $31,848,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Capital Performance Advisors LLP acquired a new stake in IQVIA during the 3rd quarter valued at $27,000. Park Place Capital Corp acquired a new position in IQVIA during the 3rd quarter worth $28,000. Itau Unibanco Holding S.A. acquired a new position in IQVIA during the 2nd quarter worth $29,000. International Assets Investment Management LLC acquired a new position in IQVIA during the 2nd quarter worth $32,000. Finally, Avior Wealth Management LLC grew its holdings in IQVIA by 117.6% during the 3rd quarter. Avior Wealth Management LLC now owns 161 shares of the medical research company's stock worth $38,000 after acquiring an additional 87 shares in the last quarter. 89.62% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on IQV shares. JPMorgan Chase & Co. decreased their price objective on shares of IQVIA from $279.00 to $240.00 and set an "overweight" rating for the company in a report on Tuesday, November 5th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $270.00 price target on shares of IQVIA in a report on Wednesday, December 4th. Morgan Stanley decreased their price target on shares of IQVIA from $280.00 to $265.00 and set an "overweight" rating for the company in a report on Monday, November 4th. TD Cowen decreased their price target on shares of IQVIA from $270.00 to $255.00 and set a "buy" rating for the company in a report on Friday, November 1st. Finally, Leerink Partners reaffirmed an "outperform" rating and issued a $248.00 price target (down from $260.00) on shares of IQVIA in a report on Tuesday, November 19th. Five investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $256.50.

IQVIA Price Performance

Shares of IQV stock traded up $3.94 during midday trading on Monday, reaching $206.57. 1,748,952 shares of the company were exchanged, compared to its average volume of 1,182,643. IQVIA Holdings Inc. has a 12 month low of $187.62 and a 12 month high of $261.73. The company has a market cap of $37.49 billion, a P/E ratio of 27.11, a PEG ratio of 2.08 and a beta of 1.49. The company's 50 day moving average price is $214.57 and its two-hundred day moving average price is $224.96. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.